Celecoxib, Durvalumab and Tremelimumab for the Treatment of Patients With Advanced or Metastatic Liver Cancer — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(4 sites)
United States
Grady Health System, Atlanta, Georgia Emory University Hospital Midtown, Atlanta, Georgia Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia Emory Saint Joseph's Hospital, Atlanta, Georgia Last updated January 2026